These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [A drive substance for the motor in digestion. Introduction]. Demling L Fortschr Med Suppl; 1990; 87():4. PubMed ID: 2351358 [No Abstract] [Full Text] [Related]
7. The place of cisapride in therapeutics: an interim verdict. Hawkey CJ Aliment Pharmacol Ther; 1991 Aug; 5(4):351-6. PubMed ID: 1777545 [No Abstract] [Full Text] [Related]
8. [Cisapride and other prokinetic agents in the treatment of gastroenterological diseases]. Ryss ES; Fishzon-Ryss IuI Ter Arkh; 1995; 67(2):58-61. PubMed ID: 7725263 [No Abstract] [Full Text] [Related]
9. Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology. McCallum RW Am J Gastroenterol; 1991 Feb; 86(2):135-49. PubMed ID: 1992624 [No Abstract] [Full Text] [Related]
10. Cisapride, a drug for long-term treatment? Harvengt C Acta Gastroenterol Belg; 1990; 53(4):369-71. PubMed ID: 2096582 [No Abstract] [Full Text] [Related]
11. [Prokinetic drugs]. Hellström P Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341 [TBL] [Abstract][Full Text] [Related]
12. [Prokinetics in reflux disease. Action mechanisms and clinical effects]. Hatlebakk JG; Berstad A Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452 [TBL] [Abstract][Full Text] [Related]
13. Cisapride. Washabau RJ; Hall JA J Am Vet Med Assoc; 1995 Nov; 207(10):1285-8. PubMed ID: 7591920 [No Abstract] [Full Text] [Related]
14. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders. Tack J; Coremans G; Janssens J Drug Saf; 1995 Jun; 12(6):384-92. PubMed ID: 8527013 [TBL] [Abstract][Full Text] [Related]
15. Cisapride marketed for use in gastroesophageal reflux disease. Clin Pharm; 1993 Dec; 12(12):876, 879. PubMed ID: 8137603 [No Abstract] [Full Text] [Related]
16. Long-term use of cisapride (prepulsid) in premature neonates of less than 34 weeks gestational age. Janssens G; Melis K; Vaerenberg M J Pediatr Gastroenterol Nutr; 1990 Oct; 11(3):420-2. PubMed ID: 2246729 [No Abstract] [Full Text] [Related]
17. [Effects of gastrointestinal-motility control agents on gastroesophageal reflux]. Sekiguchi T; Nishioka Ta; Kawamura O; Kikuchi K; Horikoshi T; Machida M; Matsuzaki T; Kusano M; Sugiyama T; Tsuchinuki M Nihon Heikatsukin Gakkai Zasshi; 1990 Apr; 26(2):78-82. PubMed ID: 2273691 [No Abstract] [Full Text] [Related]